Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic
  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Stratasys Releases First Quarter 2022 Financial Results

  • First quarter revenue of $163.4 million, 22% growth over first quarter 2021, highest first quarter revenue in six years
  • First quarter GAAP net loss of $20.9 million, or $0.32 per diluted share, and non-GAAP net income of $1.2 million, or $0.02 per diluted share
  • $475.6 million cash and equivalents and no debt as of March 31, 2022

Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced financial results for the first quarter of 2022.

Summary - First Quarter 2022 Financial Results Compared to First Quarter 2021:

  • Revenue of $163.4 million, compared to $134.2 million.
  • GAAP gross margin of 42.6%, compared to 41.4%.
  • Non-GAAP gross margin of 47.3%, compared to 46.7%.
  • GAAP operating loss of $19.6 million, compared to a GAAP operating loss of $18.4 million.
  • Non-GAAP operating income of $2.0 million, compared to non-GAAP operating loss of $2.6 million.
  • GAAP net loss of $20.9 million, or $0.32 per diluted share, compared to net loss of $18.9 million, or $0.32 per diluted share.
  • Non-GAAP net income of $1.2 million, or $0.02 per diluted share, compared to non-GAAP net loss of $3.8 million, or $0.06 per diluted share.
  • Adjusted EBITDA of $8.1 million, compared to $3.5 million.
  • $16.1 million of cash used by, compared to $22.8 million of cash generated from, operating activities, reflecting more inventory purchasing and increase in accounts receivable.

Dr. Yoav Zeif, Stratasys’ Chief Executive Officer, stated, “Our strong start to the year, with our highest first quarter revenue total in six years, was anchored by 22% revenue growth that included improved contributions from all our technologies. Importantly, systems was the main driver, up 36.7% for its strongest first quarter in five years, and 16.4% higher than the same period in pre-COVID 2019. We also achieved exceptional results in both consumables and services, driven by strength in our growing install base. And we are particularly excited by the early momentum and contributions from our new Origin P3, H350 SAF and Neo systems, designed for high-volume production of end-use parts.”

Dr. Zeif continued, “We have advanced a number of strategic initiatives thus far in 2022, including the announced MakerBot business combination with Ultimaker, the publishing of our inaugural ESG Sustainability Report, and our annual flagship manufacturing event where we showcased new offerings in materials, upgrades to existing printing platforms, and an expansion of our software capabilities. We are relentless about our focus on execution in our drive to grow our leadership position in polymer 3D printing. With our combination of best-in-class talent, systems offerings, Go-to-Market and support infrastructure, combined with a robust balance sheet, Stratasys is positioned to build on our first quarter growth across the balance of 2022 and beyond.”

Financial Outlook:

Based on current market conditions and assuming that the impact of the COVID-19 pandemic or global supply chain costs do not impede economic activity further, the Company is tightening its revenue guidance range for 2022:

  • Full year revenue of $685 million to $695 million.
  • Sequential quarterly revenue growth.
  • Second quarter revenue growth expected to reach low to mid-teens as a percentage over second quarter of 2021.
  • Based on current logistics and materials costs, full-year gross margins of flat to slightly higher than in 2021, with improved year-over-year growth in the second half of 2022.
  • Full year-operating expenses that are $20 million to $25 million higher than 2021, primarily due to ongoing investments in new products to drive higher revenue.
  • Full year non-GAAP operating margins slightly above 2%.
  • GAAP net loss of $74 million to $67 million, or ($1.11) to ($1.00) per diluted share.
  • Non-GAAP net income of $10 million to $13 million, or $0.14 to $0.19 per diluted share.
  • Adjusted EBITDA of $38 million to $41 million.
  • Capital expenditures of $20 million to $25 million.

Non-GAAP earnings guidance excludes $37 million to $38 million of projected amortization of intangible assets, $31 million to $33 million of share-based compensation expense, and reorganization and other expenses of $14 million to $15 million. Non-GAAP guidance includes tax adjustments of $2 million to $1 million on the above non-GAAP items.

Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

Stratasys Ltd. First Quarter 2022 Webcast and Conference Call Details

The Company plans to webcast its conference call to discuss its first quarter 2022 financial results on Monday, May 16, 2022, at 4:30 p.m. (ET).

The investor conference call will be available via live webcast on the Stratasys website at investors.stratasys.com, or directly at the following web address:

https://services.choruscall.com/mediaframe/webcast.html?webcastid=QiDdBAQK

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

Cautionary Statement Regarding Forward-Looking Statements

The statements in this press release regarding Stratasys' strategy, and the statements regarding Stratasys’ projected future financial performance, including the financial guidance concerning its expected results for 2022 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the degree of our success at locating and acquiring additional value-enhancing, inorganic technology that furthers our business plan to lead in the realm of polymers; the potential adverse impact that recent global interruptions and delays involving freight carriers and other third parties may have on our supply chain and distribution network, and, consequently, our ability to successfully sell both our existing and newly-launched 3D printing products; the strength and duration of, and degree of recovery from and resilience to, the COVID-19 pandemic and/or adverse macro-economic trends that are, in part, by-products of that pandemic, such as inflation, which may have significant consequences for our operations, financial position, cash flows, and those of our customers and suppliers going forward; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2021, which we filed with the U.S. Securities and Exchange Commission, or SEC, on February 24, 2022 (the “2021 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2021 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2022, which will be furnished to the SEC throughout 2022, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Use of Non-GAAP Financial Measures

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

Stratasys Ltd.
Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)
 

March 31,

 

December 31,

 

2022

 

2021

     
ASSETS    
     
Current assets    
Cash and cash equivalents  

$

293,649

 

 

$

243,179

 

Short-term deposits  

 

182,000

 

 

 

259,000

 

Accounts receivable, net of allowance for credit losses of $0.7 million and $0.5 million as of March 31, 2022 and December 31, 2021  

 

136,444

 

 

 

129,382

 

Inventories  

 

143,116

 

 

 

129,147

 

Prepaid expenses  

 

8,477

 

 

 

6,871

 

Other current assets  

 

24,185

 

 

 

33,123

 

     
Total current assets  

 

787,871

 

 

 

800,702

 

     
Non-current assets    
Property, plant and equipment, net  

 

200,627

 

 

 

203,295

 

Goodwill  

 

65,089

 

 

 

65,144

 

Other intangible assets, net  

 

143,317

 

 

 

152,244

 

Operating lease right-of-use assets  

 

14,162

 

 

 

14,651

 

Long-term investments  

 

28,667

 

 

 

28,667

 

Other non-current assets  

 

16,651

 

 

 

12,519

 

     
Total non-current assets  

 

468,513

 

 

 

476,520

 

     
Total assets  

$

1,256,384

 

 

$

1,277,222

 

     
LIABILITIES AND EQUITY    
     
Current liabilities    
Accounts payable  

$

59,010

 

 

$

51,976

 

Accrued expenses and other current liabilities  

 

44,198

 

 

 

55,358

 

Accrued compensation and related benefits  

 

38,341

 

 

 

44,684

 

Deferred revenues - short term  

 

52,337

 

 

 

51,174

 

Operating lease liabilities - short term  

 

7,158

 

 

 

7,276

 

     
Total current liabilities  

 

201,044

 

 

 

210,468

 

     
Non-current liabilities    
Deferred revenues - long term  

 

22,026

 

 

 

21,133

 

Deferred income taxes - long term  

 

6,258

 

 

 

7,341

 

Operating lease liabilities - long term  

 

7,220

 

 

 

7,693

 

Contingent consideration  

 

53,648

 

 

 

53,478

 

Other non-current liabilities  

 

23,487

 

 

 

21,095

 

     
Total non-current liabilities  

 

112,639

 

 

 

110,740

 

     
Total liabilities  

 

313,683

 

 

 

321,208

 

     
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands    
shares; 66,408 thousands shares and 65,667 thousands shares issued    
and outstanding at March 31, 2022 and December 31, 2021, respectively  

 

185

 

 

 

182

 

Additional paid-in capital  

 

3,021,166

 

 

 

3,012,481

 

Accumulated other comprehensive loss  

 

(9,824

)

 

 

(8,771

)

Accumulated deficit  

 

(2,068,826

)

 

 

(2,047,878

)

 

 

942,701

 

 

 

956,014

 

     
Total liabilities and equity  

$

1,256,384

 

 

$

1,277,222

 

Stratasys Ltd.
Consolidated Statements of Operations
(in thousands, except per share data)
     
 

Three Months Ended March 31,

 

2022

 

2021

 

(unaudited)

 

(unaudited)

Net sales    
Products  

$

113,073

 

 

$

90,324

 

Services  

 

50,356

 

 

 

43,865

 

 

 

163,429

 

 

 

134,189

 

     
Cost of sales    
Products  

 

59,373

 

 

 

46,920

 

Services  

 

34,379

 

 

 

31,692

 

 

 

93,752

 

 

 

78,612

 

     
Gross profit  

 

69,677

 

 

 

55,577

 

     
Operating expenses    
Research and development, net  

 

23,998

 

 

 

20,601

 

Selling, general and administrative  

 

65,263

 

 

 

53,334

 

 

 

89,261

 

 

 

73,935

 

     
Operating loss  

 

(19,584

)

 

 

(18,358

)

     
Financial expense, net  

 

(1,362

)

 

 

(377

)

     
Loss before income taxes  

 

(20,946

)

 

 

(18,735

)

     
Income tax benefit  

 

73

 

 

 

942

 

     
Share in losses of associated companies  

 

(75

)

 

 

(1,118

)

     
Net loss  

$

(20,948

)

 

$

(18,911

)

     
Net loss per share    
Basic  

$

(0.32

)

 

$

(0.32

)

Diluted  

$

(0.32

)

 

$

(0.32

)

     
Weighted average ordinary shares outstanding    
Basic  

 

65,721

 

 

 

58,616

 

Diluted  

 

65,721

 

 

 

58,616

 

 

Three Months Ended March 31,

 

2022

 

Non-GAAP

 

2022

 

2021

 

Non-GAAP

 

2021

 

GAAP

 

Adjustments

 

Non-GAAP

 

GAAP

 

Adjustments

 

Non-GAAP

 

U.S. dollars and shares in thousands (except per share amounts)

             
Gross profit (1)  

$

69,677

 

 

$

7,689

 

 

$

77,366

 

$

55,577

 

 

$

7,069

 

 

$

62,646

 

Operating income (loss) (1,2)  

 

(19,584

)

 

 

21,607

 

 

 

2,023

 

 

(18,358

)

 

 

15,785

 

 

$

(2,573

)

Net income (loss) attributable to Stratasys Ltd. (1,2,3)  

 

(20,948

)

 

 

22,158

 

 

 

1,210

 

 

(18,911

)

 

 

15,111

 

 

$

(3,800

)

Net income (loss) per diluted share attributable to Stratasys Ltd. (4)  

$

(0.32

)

 

$

0.34

 

 

$

0.02

 

$

(0.32

)

 

$

0.26

 

 

$

(0.06

)

             
             
             

(1)

Acquired intangible assets amortization expense    

 

6,966

 

     

 

5,356

 

 
Non-cash stock-based compensation expense    

 

900

 

     

 

634

 

 
Restructuring and other related costs    

 

(177

)

     

 

1,079

 

 
   

 

7,689

 

     

 

7,069

 

 
             

(2)

Acquired intangible assets amortization expense    

 

2,225

 

     

 

2,192

 

 
Non-cash stock-based compensation expense    

 

7,633

 

     

 

6,571

 

 
Restructuring and other related costs    

 

555

 

     

 

1,810

 

 
Revaluation of investments    

 

1,061

 

     

 

(3,670

)

 
Contingent consideration    

 

207

 

     

 

191

 

 
Other expenses    

 

2,237

 

     

 

1,622

 

 
   

 

13,918

 

     

 

8,716

 

 
   

 

21,607

 

     

 

15,785

 

 
             

(3)

Corresponding tax effect and other expenses    

 

551

 

     

 

(674

)

 
   

$

22,158

 

     

$

15,111

 

 
             

(4)

Weighted average number of ordinary shares outstanding- Diluted  

 

65,721

 

   

 

67,060

 

 

58,616

 

   

 

58,616

 

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.